HIC2 promotes cell cycle transitions by upregulating CDK1 expression in glioblastoma

• Peifen Lu,
• Wenbing Shangguan,
• Quan Zhao

Affiliations

Peifen Lu

The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, Nanjing, China

Wenbing Shangguan

The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, Nanjing, China

Quan Zhao

Corresponding author. 163 Xianlin Avenue, Qixia District, Nanjing, 210023, China.; The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, Nanjing, China